Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine supported exposure therapy in panic disorder
2006-004860-29Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of d-cycloserine in panic disorder and agoraphobia, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Panic and Agoraphobia Scale total score. Started Dec 2006; status: completed.
02
Drugs
d-cycloserine
03
Conditions
panic disorderagoraphobia
Beyond the preview
Go deeper on 2006-004860-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004860-29.